Literature DB >> 7983721

Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1.

R Bernier1, M Tremblay.   

Abstract

Defective particles are naturally occurring virus mutants that lack one or more genes required for viral replication. Such viruses may affect positively or negatively the symptoms of the disease. Thus, it is of great interest to measure the role played by defective particles in the process of human immunodeficiency virus (HIV) infection since accumulating evidence indicates that a great proportion of HIV genomes are defective. We used defective particles produced by two stable cellular clones (UHC-8 and UHC-18) to investigate whether they can affect replication of infectious viral particles generated by a human T-cell line transfected with a molecular HIV-1 clone. Progeny virus harvested from UHC-8 cells has no reverse transcriptase and integrase proteins, while UHC-18 has no reverse transcriptase protein. We demonstrate here that coinoculation of a T-lymphoid cell line and of peripheral blood mononuclear cells with defective and infectious particles leads to a dramatic inhibition of virus replication. Defective particles do not interfere with virus production from proviral DNA. Rather, the inhibition of reinfection events seems to be their mechanism of action. This model closely parallels the in vivo conditions and demonstrates that defective particles may limit the spread of infection and progression of the disease by reducing the yield of infectious virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7983721      PMCID: PMC188575          DOI: 10.1128/JVI.69.1.291-300.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

Authors:  B R Starcich; B H Hahn; G M Shaw; P D McNeely; S Modrow; H Wolf; E S Parks; W P Parks; S F Josephs; R C Gallo
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

2.  Genetic variation in AIDS viruses.

Authors:  J M Coffin
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

3.  HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions.

Authors:  M Goodenow; T Huet; W Saurin; S Kwok; J Sninsky; S Wain-Hobson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

4.  Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression.

Authors:  M Green; M Ishino; P M Loewenstein
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

5.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 7.  Rapid evolution of RNA viruses.

Authors:  D A Steinhauer; J J Holland
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

Review 8.  Origin and replication of defective interfering particles.

Authors:  J Perrault
Journal:  Curr Top Microbiol Immunol       Date:  1981       Impact factor: 4.291

9.  Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus.

Authors:  M L Poss; J I Mullins; E A Hoover
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

10.  Recovery of avian sarcoma virus from tumors induced by transformation-defective mutants.

Authors:  H Hanafusa; C C Halpern; D L Buchhagen; S Kawai
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  7 in total

1.  gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.

Authors:  P D'Aloja; E Olivetta; R Bona; F Nappi; D Pedacchia; K Pugliese; G Ferrari; P Verani; M Federico
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule.

Authors:  P Bérubé; B Barbeau; R Cantin; R P Sékaly; M Tremblay
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

3.  Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay.

Authors:  B Barbeau; J F Fortin; N Genois; M J Tremblay
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

4.  Involvement of a spliced and defective human foamy virus in the establishment of chronic infection.

Authors:  A Saïb; M H Koken; P van der Spek; J Périès; H de Thé
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

5.  Optimized Infectivity of the Cell-Free Single-Cycle Human Immunodeficiency Viruses Type 1 (HIV-1) and Its Restriction by Host Cells.

Authors:  Jin H Kim; Hanna Song; Jamie L Austin; Wei Cheng
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

6.  Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain.

Authors:  Beihui Liu; Shu Wang; Michael Brenner; Julian F R Paton; Sergey Kasparov
Journal:  J Gene Med       Date:  2008-05       Impact factor: 4.565

7.  Flow Virometry Quantification of Host Proteins on the Surface of HIV-1 Pseudovirus Particles.

Authors:  Jonathan Burnie; Vera A Tang; Joshua A Welsh; Arvin T Persaud; Laxshaginee Thaya; Jennifer C Jones; Christina Guzzo
Journal:  Viruses       Date:  2020-11-12       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.